Ahmed Aijaz, Keeffe Emmet B
Division of Gastroenterology and Hepatology, Liver Transplant Program, Stanford University School of Medicine, Stanford, CA 94304, USA.
Clin Liver Dis. 2007 May;11(2):227-47. doi: 10.1016/j.cld.2007.04.008.
Survival rates after liver transplantation have improved steadily because of earlier referral and timely evaluation, judicious patient selection, improved surgical techniques, superior immunosuppressive regimens, and effective prevention of perioperative opportunistic infections. Indications and contraindications for liver transplantation are undergoing constant modifications with the goal of improving survival and functional status of patients who have end-stage liver disease or acute liver failure. Potential candidates for liver transplantation should meet minimal listing criteria and not have contraindications to liver transplantation. Currently, the Model for End-stage Liver Disease score is used for organ allocation, but it may have future application in patient-selection criteria.
由于更早的转诊和及时的评估、明智的患者选择、改进的手术技术、更优的免疫抑制方案以及围手术期机会性感染的有效预防,肝移植后的生存率稳步提高。肝移植的适应证和禁忌证正在不断调整,目的是提高终末期肝病或急性肝衰竭患者的生存率和功能状态。肝移植的潜在候选人应符合最低列入标准,且没有肝移植的禁忌证。目前,终末期肝病模型评分用于器官分配,但它可能在未来用于患者选择标准。